AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
208.84
-6.14 (-2.86%)
At close: Apr 2, 2026, 4:00 PM EDT
208.96
+0.12 (0.06%)
After-hours: Apr 2, 2026, 7:58 PM EDT
AbbVie Employees
AbbVie had 57,000 employees as of December 31, 2025. The number of employees increased by 2,000 or 3.64% compared to the previous year.
Employees
57,000
Change (1Y)
2,000
Growth (1Y)
3.64%
Revenue / Employee
$1,072,982
Profits / Employee
$73,439
Market Cap
369.39B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57,000 | 2,000 | 3.64% |
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | 0 | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| Eli Lilly and Company | 50,000 |
ABBV News
- 9 hours ago - Trump Administration Unveils Up to 100% Tariff on Branded Drugs - WSJ
- 9 hours ago - Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices - The Guardian
- 11 hours ago - Drugmakers face 100% tariff unless they cut prices or produce drugs in US - Reuters
- 12 hours ago - Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
- 2 days ago - Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® - PRNewsWire
- 2 days ago - AbbVie to Host First-Quarter 2026 Earnings Conference Call - PRNewsWire
- 6 days ago - AbbVie: Strong 2026 Outlook, Expect Dividend Increases - Seeking Alpha
- 6 days ago - AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting - PRNewsWire